Short-Term Debt to Capital: Paragon 28 Corp (FNA)

Paragon 28, Inc. (FNA) dominates the ankle instrument and implant segment due to unique patents and the high switching costs for surgeons moving to alternative systems. This chart on GURU.Markets shows the asset value at 0.07, confirming its market position. A personalized approach to pathologies provides the company with pricing power, while experienced management successfully expands global sales.

The implementation of environmental standards for instrument recycling by Paragon 28, Inc. (FNA) requires operational expenditures; consequently, the trend in short-term loans to equity reflects the dependence of refinancing cycles on the volume of current liabilities under one year. This indicator measures the risk of cash gaps relative to the capital base, allowing investors to assess how effectively the company balances accelerating inventory turnover with long-term asset sustainability.